Tapewire

NYSE · USD

EVMN

Evommune, Inc.

Export transactions ↓
Tapewire entity
5539
SEC CIK
0002044725
Parsed reports
64

Last 12 months

Inside the activity.

7 purchase rows · 9 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202510
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202607
Jul 202620
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 05, 2025 Filed Nov 7, 2025 21:15 UTC
Patel Jeegar PravinkumarChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 179,619 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0002092017-25-000005 · form4-11072025_041109.xml · derivative · entry 1

Patel Jeegar Pravinkumar · CIK 0002092017 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,619

Underlying: Common Stock · 179,619 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC
Drew Janice SuzannEVP, Operations
GrantEmployee Stock Option (Right to Buy) · Derivative 231,274 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0002091053-25-000005 · form4-11072025_041107.xml · derivative · entry 1

Drew Janice Suzann · CIK 0002091053 · EVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231,274

Underlying: Common Stock · 231,274 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC GrantStock Option (Right to Buy) · Derivative 37,960 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001347383-25-000007 · form4-11072025_041114.xml · derivative · entry 1

Cohen David E · CIK 0001347383 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,960

Underlying: Common Stock · 37,960 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One third (1/3) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC GrantStock Option (Right to Buy) · Derivative 37,960 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001290976-25-000010 · form4-11072025_041112.xml · derivative · entry 1

KIRSCH ARTHUR S · CIK 0001290976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,960

Underlying: Common Stock · 37,960 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One third (1/3) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC GrantStock Option (Right to Buy) · Derivative 37,960 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001216994-25-000008 · form4-11072025_041110.xml · derivative · entry 1

MCGRAW BENJAMIN F III · CIK 0001216994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,960

Underlying: Common Stock · 37,960 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One third (1/3) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC
Carver KyleChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 279,408 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001757072-25-000006 · form4-11072025_041105.xml · derivative · entry 1

Carver Kyle · CIK 0001757072 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,408

Underlying: Common Stock · 279,408 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC
Pena Luis C.Director · President & CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 796,841 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001620548-25-000007 · form4-11072025_041102.xml · derivative · entry 1

Pena Luis C. · CIK 0001620548 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 796,841

Underlying: Common Stock · 796,841 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:15 UTC
Moss Gregory S.Chief Business & Legal Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 293,496 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001742496-25-000008 · form4-11072025_041104.xml · derivative · entry 1

Moss Gregory S. · CIK 0001742496 · Chief Business & Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,496

Underlying: Common Stock · 293,496 shares

Expires 2035-11-04

F1 · derivative.exercise_date: One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.